[HTML][HTML] Mechanisms of action of fluvoxamine for COVID-19: a historical review
Y Hashimoto, T Suzuki, K Hashimoto - Molecular psychiatry, 2022 - nature.com
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) accelerates the discovery of …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) accelerates the discovery of …
[HTML][HTML] Overview of the potential use of fluvoxamine for COVID-19 and long COVID
K Hashimoto - Discover Mental Health, 2023 - Springer
Abstract Coronavirus disease 2019 (COVID-19) has presented a serious worldwide threat to
public health since its emergence in late 2019. From a safety point of view, drug repurposing …
public health since its emergence in late 2019. From a safety point of view, drug repurposing …
[HTML][HTML] Simvastatin downregulates the SARS-CoV-2-induced inflammatory response and impairs viral infection through disruption of lipid rafts
Coronavirus disease 2019 (COVID-19) is currently a worldwide emergency caused by
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In observational clinical …
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In observational clinical …
[HTML][HTML] Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up
GY Cui, BC Rao, ZH Zeng, XM Wang, T Ren… - Military Medical …, 2022 - Springer
Background Due to the outbreak and rapid spread of coronavirus disease 2019 (COVID-19),
more than 160 million patients have become convalescents worldwide to date. Significant …
more than 160 million patients have become convalescents worldwide to date. Significant …
Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort
CL Clelland, K Ramiah, L Steinberg, JD Clelland - BJPsych Open, 2022 - cambridge.org
BackgroundDuring the first wave of the coronavirus disease 2019 (COVID-19) pandemic,
patients with confirmed cases in New York State accounted for roughly 25% of total US …
patients with confirmed cases in New York State accounted for roughly 25% of total US …
Bioinformatics and system biology approaches to identify pathophysiological impact of COVID-19 to the progression and severity of neurological diseases
Abstract The Coronavirus Disease 2019 (COVID-19) still tends to propagate and increase
the occurrence of COVID-19 across the globe. The clinical and epidemiological analyses …
the occurrence of COVID-19 across the globe. The clinical and epidemiological analyses …
[HTML][HTML] Saliva metabolomic profile of COVID-19 patients associates with disease severity
N Saheb Sharif-Askari, NC Soares, HA Mohamed… - Metabolomics, 2022 - Springer
Abstract Introduction Coronavirus disease 2019 (COVID-19) is strongly linked to
dysregulation of various molecular, cellular, and physiological processes that change …
dysregulation of various molecular, cellular, and physiological processes that change …
Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology
EB Vitner, R Avraham, B Politi… - Life science …, 2022 - life-science-alliance.org
Understanding pathways that might impact coronavirus disease 2019 (COVID-19)
manifestations and disease outcomes is necessary for better disease management and for …
manifestations and disease outcomes is necessary for better disease management and for …
[HTML][HTML] Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection
Host anti-viral factors are essential for controlling SARS-CoV-2 infection but remain largely
unknown due to the biases of previous large-scale studies toward pro-viral host factors. To …
unknown due to the biases of previous large-scale studies toward pro-viral host factors. To …
[HTML][HTML] The manifold roles of sphingolipids in viral infections
E Avota, J Bodem, J Chithelen, P Mandasari… - Frontiers in …, 2021 - frontiersin.org
Sphingolipids are essential components of eukaryotic cells. In this review, we want to
exemplarily illustrate what is known about the interactions of sphingolipids with various …
exemplarily illustrate what is known about the interactions of sphingolipids with various …